TY - JOUR
T1 - Genotype correlates with the natural history of severe bile salt export pump deficiency
AU - van Wessel, Daan B E
AU - Thompson, Richard J
AU - Gonzales, Emmanuel
AU - Jankowska, Irena
AU - Sokal, Etienne
AU - Grammatikopoulos, Tassos
AU - Kadaristiana, Agustina
AU - Jacquemin, Emmanuel
AU - Spraul, Anne
AU - Lipiński, Patryk
AU - Czubkowski, Piotr
AU - Rock, Nathalie
AU - Shagrani, Mohammad
AU - Broering, Dieter
AU - Algoufi, Talal
AU - Mazhar, Nejat
AU - Nicastro, Emanuele
AU - Kelly, Deirdre
AU - Nebbia, Gabriella
AU - Arnell, Henrik
AU - Fischler, Bjo Rn
AU - Hulscher, Jan B F
AU - Serranti, Daniele
AU - Arikan, Cigdem
AU - Polat, Esra
AU - Debray, Dominique
AU - Lacaille, Florence
AU - Goncalves, Cristina
AU - Hierro, Loreto
AU - Muñoz Bartolo, Gema
AU - Mozer-Glassberg, Yael
AU - Azaz, Amer
AU - Brecelj, Jernej
AU - Dezsőfi, Antal
AU - Calvo, Pier Luigi
AU - Grabhorn, Enke
AU - Sturm, Ekkehard
AU - van der Woerd, Wendy J
AU - Kamath, Binita M
AU - Wang, Jian-She
AU - Li, Liting
AU - Durmaz, Özlem
AU - Onal, Zerrin
AU - Bunt, Ton Mg
AU - Hansen, Bettina
AU - Verkade, Henkjan J
N1 - Copyright © 2020. Published by Elsevier B.V.
PY - 2020/7
Y1 - 2020/7
N2 - Background & Aims: Mutations in ABCB11 can cause deficiency of the bile salt export pump (BSEP), leading to cholestasis and end-stage liver disease. Owing to the rarity of the disease, the associations between genotype and natural history, or outcomes following surgical biliary diversion (SBD), remain elusive. We aimed to determine these associations by assembling the largest genetically defined cohort of patients with severe BSEP deficiency to date. Methods: This multicentre, retrospective cohort study included 264 patients with homozygous or compound heterozygous pathological ABCB11 mutations. Patients were categorized according to genotypic severity (BSEP1, BSEP2, BSEP3). The predicted residual BSEP transport function decreased with each category. Results: Genotype severity was strongly associated with native liver survival (NLS, BSEP1 median 20.4 years; BSEP2, 7.0 years; BSEP3, 3.5 years; p <0.001). At 15 years of age, the proportion of patients with hepatocellular carcinoma was 4% in BSEP1, 7% in BSEP2 and 34% in BSEP3 (p = 0.001). SBD was associated with significantly increased NLS (hazard ratio 0.50; 95% CI 0.27–0.94: p = 0.03) in BSEP1 and BSEP2. A serum bile acid concentration below 102 μmol/L or a decrease of at least 75%, each shortly after SBD, reliably predicted NLS of ≥15 years following SBD (each p <0.001). Conclusions: The genotype of severe BSEP deficiency strongly predicts long-term NLS, the risk of developing hepatocellular carcinoma, and the chance that SBD will increase NLS. Serum bile acid parameters shortly after SBD can predict long-term NLS. Lay summary: This study presents data from the largest genetically defined cohort of patients with severe bile salt export pump deficiency to date. The genotype of patients with severe bile salt export pump deficiency is associated with clinical outcomes and the success of therapeutic interventions. Therefore, genotypic data should be used to guide personalized clinical care throughout childhood and adulthood in patients with this disease.
AB - Background & Aims: Mutations in ABCB11 can cause deficiency of the bile salt export pump (BSEP), leading to cholestasis and end-stage liver disease. Owing to the rarity of the disease, the associations between genotype and natural history, or outcomes following surgical biliary diversion (SBD), remain elusive. We aimed to determine these associations by assembling the largest genetically defined cohort of patients with severe BSEP deficiency to date. Methods: This multicentre, retrospective cohort study included 264 patients with homozygous or compound heterozygous pathological ABCB11 mutations. Patients were categorized according to genotypic severity (BSEP1, BSEP2, BSEP3). The predicted residual BSEP transport function decreased with each category. Results: Genotype severity was strongly associated with native liver survival (NLS, BSEP1 median 20.4 years; BSEP2, 7.0 years; BSEP3, 3.5 years; p <0.001). At 15 years of age, the proportion of patients with hepatocellular carcinoma was 4% in BSEP1, 7% in BSEP2 and 34% in BSEP3 (p = 0.001). SBD was associated with significantly increased NLS (hazard ratio 0.50; 95% CI 0.27–0.94: p = 0.03) in BSEP1 and BSEP2. A serum bile acid concentration below 102 μmol/L or a decrease of at least 75%, each shortly after SBD, reliably predicted NLS of ≥15 years following SBD (each p <0.001). Conclusions: The genotype of severe BSEP deficiency strongly predicts long-term NLS, the risk of developing hepatocellular carcinoma, and the chance that SBD will increase NLS. Serum bile acid parameters shortly after SBD can predict long-term NLS. Lay summary: This study presents data from the largest genetically defined cohort of patients with severe bile salt export pump deficiency to date. The genotype of patients with severe bile salt export pump deficiency is associated with clinical outcomes and the success of therapeutic interventions. Therefore, genotypic data should be used to guide personalized clinical care throughout childhood and adulthood in patients with this disease.
KW - Severe BSEP deficiency
KW - PFIC2
KW - ABCB11
KW - Natural history
KW - Surgical biliary diversion
KW - FAMILIAL INTRAHEPATIC CHOLESTASIS
KW - EXTERNAL BILIARY DIVERSION
KW - SURGICAL-MANAGEMENT
KW - ABCB11 MUTATIONS
KW - CHILDREN
KW - LIVER
KW - TYPE-2
KW - BSEP
KW - EXPRESSION
KW - OUTCOMES
U2 - 10.1016/j.jhep.2020.02.007
DO - 10.1016/j.jhep.2020.02.007
M3 - Article
C2 - 32087350
SN - 0168-8278
VL - 73
SP - 84
EP - 93
JO - Journal of Hepatology
JF - Journal of Hepatology
IS - 1
ER -